Myolex is disrupting how to measure muscle wasting (and treatment), caused by obesity drugs, aging, and sport injuries. Myolex® EIM is a patented device technology and SaaS data analytics platform that is built to disrupt skeletal muscle measurement by becoming the clinical and wellness standard to aid in the diagnosis and treatment of obesity drug and age-related muscle wasting. Myolex has developed the 1st quantitative, sensitive, painless, portable for home use muscle quality assessment device that is specifically designed to non-invasively, comprehensibly, and precisely detect and monitor single muscle wasting.
| Website | http://www.myolex.com/ |
| Employees | 7 (3 on RocketReach) |
| Founded | 2009 |
| Address | Beacon St, Brookline, Massachusetts, US |
| Phone | +1 888-382-8824 |
| Technologies |
JavaScript
,
HTML
,
PHP
+7 more
(view full list)
|
| Industry | Medical Equipment Manufacturing |
| Keywords | Body Composition Analysis, Sports Injury Rehabilitation, Remote Patient Monitoring, Data Analytics For Healthcare |
| Competitors | Siemens Healthineers, Roche, Thermo Fisher Scientific, Abbott, BD, Merck Group, Agilent Technologies, Illumina, PerkinElmer, Inc., Bio-Rad Laboratories +48 more (view full list) |
Looking for a particular Myolex employee's phone or email?
Neil Lupton is the Interim President of Myolex.
3 people are employed at Myolex.
Myolex is based in Brookline, Massachusetts.